• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用噻苯达唑成功治疗黄曲霉所致角膜炎。

Keratitis due to Aspergillus flavus successfully treated with thiabendazole.

作者信息

Upadhyay M P, West E P, Sharma A P

出版信息

Br J Ophthalmol. 1980 Jan;64(1):30-2. doi: 10.1136/bjo.64.1.30.

DOI:10.1136/bjo.64.1.30
PMID:6766732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1039343/
Abstract

A case of Aspergillus flavus keratitis treated successfully with 4% suspension of thiabendazole is reported. This seems to be the first case of successful treatment of keratomycosis with thiabendazole. All other reported cases treated with this drug either had their eyes removed or did not retain any useful vision. Its ability to penetrate ocular tissues, ability to remain in concentrations higher than the minimal inhibitory concentration of many fungi, and broad spectrum of activity make it a worthwhile drug for further investigation in keratomycosis.

摘要

报告了1例用4%噻苯达唑混悬液成功治疗的黄曲霉角膜炎病例。这似乎是首例用噻苯达唑成功治疗角膜真菌病的病例。其他所有用该药治疗的报告病例要么眼球被摘除,要么未保留任何有用视力。其穿透眼组织的能力、保持高于许多真菌最低抑菌浓度的浓度的能力以及广谱活性,使其成为一种值得在角膜真菌病中进一步研究的药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5dd/1039343/e8dcb04184d3/brjopthal00193-0039-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5dd/1039343/b84d73b620cd/brjopthal00193-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5dd/1039343/e8dcb04184d3/brjopthal00193-0039-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5dd/1039343/b84d73b620cd/brjopthal00193-0038-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5dd/1039343/e8dcb04184d3/brjopthal00193-0039-a.jpg

相似文献

1
Keratitis due to Aspergillus flavus successfully treated with thiabendazole.用噻苯达唑成功治疗黄曲霉所致角膜炎。
Br J Ophthalmol. 1980 Jan;64(1):30-2. doi: 10.1136/bjo.64.1.30.
2
Aspergillus flavus keratomycosis in a cat treated with topical 1% voriconazole solution.一只猫患黄曲霉性角膜真菌病,用1%伏立康唑溶液局部治疗。
Vet Ophthalmol. 2009 Jan-Feb;12(1):48-52. doi: 10.1111/j.1463-5224.2009.00673.x.
3
Aspergillus flavus keratitis.黄曲霉角膜炎
Ann Ophthalmol. 1978 Apr;10(4):415-8.
4
Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis.脂质体伊曲康唑制剂对实验性曲霉菌属角膜炎伴眼内炎的抗真菌活性。
Mycopathologia. 2015 Apr;179(3-4):225-9. doi: 10.1007/s11046-014-9837-2. Epub 2014 Nov 28.
5
Ketoconazole: a new imidazole antifungal agent has both prophylactic potential and therapeutic efficacy in keratomycosis of rabbits.酮康唑:一种新型咪唑类抗真菌剂对兔角膜真菌病既有预防潜力又有治疗效果。
Int Ophthalmol. 1982 Nov;5(3):163-7. doi: 10.1007/BF00149147.
6
Equine keratomycosis in Japan.日本的马角膜真菌病。
Vet Ophthalmol. 2013 Jan;16(1):1-9. doi: 10.1111/j.1463-5224.2012.01004.x. Epub 2012 Feb 28.
7
Aspergillus flavus Keratitis: Experience of a Tertiary Eye Clinic in Turkey.黄曲霉菌角膜炎:土耳其一家三级眼科诊所的经验。
Mycopathologia. 2017 Apr;182(3-4):379-385. doi: 10.1007/s11046-016-0089-1. Epub 2016 Nov 8.
8
Diagnosis of Aspergillus keratitis in vivo with confocal microscopy.共聚焦显微镜在体内诊断曲霉菌性角膜炎
Cornea. 1997 Jan;16(1):27-31.
9
Impact of fungal species cultured on outcome in horses with fungal keratitis.培养出的真菌种类对马真菌性角膜炎预后的影响。
Vet Ophthalmol. 2017 Mar;20(2):140-146. doi: 10.1111/vop.12381. Epub 2016 Apr 7.
10
[Aspergillus oryzae as a cause of keratomycosis in the horse].米曲霉作为马角膜真菌病的病因
Tierarztl Prax. 1984;12(4):489-92.

引用本文的文献

1
Susceptibility of Dermatophytes to Thiabendazole Using CLSI Broth Macrodilution.采用CLSI肉汤大稀释法检测皮肤癣菌对噻苯达唑的敏感性。
ISRN Dermatol. 2012;2012:351842. doi: 10.5402/2012/351842. Epub 2012 Sep 13.
2
Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay.利用改良的高通量秀丽隐杆线虫 assay 鉴定抗白色念珠菌的抗真菌化合物。
PLoS One. 2009 Sep 14;4(9):e7025. doi: 10.1371/journal.pone.0007025.

本文引用的文献

1
STUDIES ON THE TOXICOLOGIC AND PHARMACOLOGIC PROPERTIES OF THIABENDAZOLE.
Toxicol Appl Pharmacol. 1965 Jan;7:53-63. doi: 10.1016/0041-008x(65)90074-8.
2
ANTIMYCOTIC PROPERTIES OF THIABENDAZOLE.噻苯达唑的抗真菌特性。
J Invest Dermatol. 1964 Jun;42:479-82. doi: 10.1038/jid.1964.101.
3
Ocular absorption of thiabendazole-14 -C by the rabbit.家兔对噻苯达唑-14-C的眼部吸收
Am J Ophthalmol. 1966 Oct;62(4):710-5. doi: 10.1016/0002-9394(66)92200-8.
4
Keratochromomycosis.角膜色真菌病
Arch Ophthalmol. 1966 Dec;76(6):811-6. doi: 10.1001/archopht.1966.03850010813006.
5
Preliminary report on the antimycotic effect of topical thiabendazole "in vivo".局部应用噻苯达唑“体内”抗真菌作用的初步报告。
Curr Ther Res Clin Exp. 1965 Sep;7(9):558-61.
6
Thiabendazole: toxicological, pharmacological and antifungal properties.
Tex Rep Biol Med. 1969 Nov;27:Suppl 2:537+.
7
Clotrimazole in the treatment of ocular infection by Aspergillus fumigatus.克霉唑治疗烟曲霉引起的眼部感染
Postgrad Med J. 1974 Jul;50 Suppl 1:39-45.
8
Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture.
Am J Ophthalmol. 1975 May;79(5):719-51. doi: 10.1016/0002-9394(75)90730-8.
9
Laboratory tests of antifungal drugs.抗真菌药物的实验室检测
J Clin Pathol. 1975 Oct;28(10):767-74. doi: 10.1136/jcp.28.10.767.